Congratulations! Approval was granted by TFDA for a phase II cell therapy clinical trial study
UPDATE : 2019/09/12
The VCRO's partner completed the phase I clinical trial and the trial report was successfully approved by TFDA recently. Congratulations to them, a phase II cell therapy clinical trial was granted by TFDA on 2019/09/11. It was a phase II cell therapy drug trial for chronic stroke used for IND-registration. VCRO has been providing a full range of services in the field of cell therapy to help partners achieve new drug R&D milestones. Our partner have granted by the authorities and VCRO was deeply honored!